What is Chemed Corp (CHE) stock price today?

Chemed Corp (CHE) is currently trading at $499.82, up 0.32% today.

What is CHE P/E ratio?

Chemed Corp's P/E ratio is 25.48. This is near the market average.

What is CHE return on equity (ROE)?

Chemed Corp's return on equity (ROE) is 29.45%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Chemed Corp's market cap?

Chemed Corp has a market capitalization of $6.53B.

NYSE · Medical - Care Facilities

Chemed Corp (CHE) Stock

$499.82 +0.32% NYSE: CHE Healthcare

Valuation

Metric	Value
Price	$499.82
Market Cap	$6.53B
P/E Ratio	25.48
P/B Ratio	8.20
P/S Ratio	2.56
EPS (TTM)	$0.00
52-Week High	$557.00
52-Week Low	$365.21
Dividend Yield	0.55%

Financials & Margins

Metric	Value
ROE	29.45%
ROA	17.41%
ROCE	27.72%
Gross Margin	13.36%
Operating Margin	13.36%
Net Margin	10.60%
Debt/Equity	0.40
Current Ratio	1.06

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.1B	$2.1B	$2.3B	$2.4B	$2.5B
Operating Profit	$343.0M	$343.0M	$341.0M	$366.0M	$338.0M
Net Profit	$269.0M	$250.0M	$273.0M	$302.0M	$265.0M
EPS	$16.85	$16.53	$17.93	$19.89	$18.42
Op Margin	16.0%	16.1%	15.0%	15.1%	13.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.3B	$1.4B	$1.7B	$1.7B	$1.6B
Total Liabilities	$719.0M	$643.0M	$560.0M	$550.0M	$661.0M
Cash	$33.0M	$74.0M	$264.0M	$178.0M	$75.0M
Borrowings	$324.0M	$247.0M	$155.0M	$141.0M	$155.0M

Latest News

Lawyer says substance found after fatal Houston ICE shooting was salt USA TODAY · Jul 17, 2026 AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly Insider Monkey · Jul 17, 2026 Why Union Pacific Stock Chugged Almost 4% Higher on Thursday Motley Fool · Jul 17, 2026 Market Chatter: UK's Burnham Said He Plans North Sea Drilling, Thames Water Nationalization MT Newswires · Jul 17, 2026 3 Reasons to Sell DECK and 1 Stock to Buy Instead StockStory · Jul 17, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$309.0M	$310.0M	$330.0M	$417.0M	$388.0M
Investing Cash Flow	$-116.0M	$-117.0M	$-117.0M	$-193.0M	$-122.0M
Financing Cash Flow	$-555.0M	$-88.0M	$25.0M	$-316.0M	$-439.0M
Net Cash Flow	$-130.0M	$41.0M	$190.0M	$-86.0M	$-104.0M
Free Cash Flow	$250.0M	$253.0M	$273.0M	$368.0M	$325.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	17.25
EV / EBITDA	16.03
FCF Yield	4.88%
Quick Ratio	0.89
Interest Coverage	72.40
Return 1Y	14.52%
Return 3Y	0.78%
Return 5Y	9.22%

Ownership

Insiders Held2.06%

Institutions Held103.36%

Institutions Float Held105.53%

Institutional Holder	Shares	Report Date
Blackrock Inc.	1,336,690	2026-03-31
Vanguard Portfolio Management LLC	815,699	2026-03-31
Vanguard Capital Management LLC	636,070	2026-03-31
JPMORGAN CHASE & CO	500,987	2026-03-31
State Street Corporation	462,170	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$336.64	-1.11%	38.93	$4.94T	0.32%
MSFTMicrosoft Corporation	$535.07	+2.38%	28.68	$3.97T	0.76%
GOOGLAlphabet Inc.	$351.66	+0.97%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$262.43	+3.29%	19.82	$2.82T	0.00%
METAMeta Platforms, Inc.	$718.67	-0.31%	27.93	$1.83T	0.28%

About Chemed Corp

Chemed Corp is led by CEO Kevin J. McNamara, employs 15,811 people, headquartered in Cincinnati, US, publicly traded since 1973.

Chemed Corp (CHE) stock trades at $499.82 with a market capitalization of $6.53B. The stock is valued at a price-to-earnings (P/E) ratio of 25.48, price-to-book of 8.20, price-to-sales of 2.56. Over the past 52 weeks the stock has ranged between $365.21 and $557.00, and currently trades 10.3% below its 52-week high. It pays a dividend yielding 0.55%.

On profitability, Chemed Corp generates a return on equity (ROE) of 29.45% — well above the market average, a sign of a high-quality business, return on capital employed of 27.72%, an operating margin of 13.36%, a net profit margin of 10.60%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides